Medical News

RSS

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

29 Oct 2018

Home blood pressure measurements can be used to diagnose hypertension in U.S. adults

Blood pressure readings of 130/80 millimeters of mercury (mm Hg) or higher taken at home can be used to diagnose hypertension in white, black and Hispanic U.S. adults, according to new research in the American Heart Association's journal Hypertension.

29 Oct 2018

Experimental vaccine shows promise to protect stroke survivors from blood clots

A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the American Heart Association's journal Hypertension.

29 Oct 2018

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

29 Oct 2018

Study finds kill code mechanism embedded in every cell to extinguish cancer

A kill code is embedded in every cell in the body whose function may be to cause the self-destruction of cells that become cancerous, reports a new Northwestern Medicine study. As soon as the cell's inner bodyguards sense it is mutating into cancer, they punch in the kill code to extinguish the mutating cell.

29 Oct 2018

Study reveals one in ten people may opt-out of proposed system for organ donation

A new study has revealed that around one in 10 people are considering opting out of a proposed new system that aims to increase organ donation by presuming consent.

29 Oct 2018

Researchers develop new app that reminds users to relax and prevent stress

Whether at work or at leisure - more and more people are feeling stressed. This makes it all the more important to learn to consciously relax in order to get stress under control.

29 Oct 2018

That’s a lot of scratch: The $48,329 allergy test

Janet Winston had a rash that wouldn't go away. The English professor from Eureka, Calif., always had been sensitive to ingredients in skin creams and cosmetics. This time, however, the antifungal cream she was prescribed to treat her persistent rash seemed to make things worse. Was she allergic to that, too?

29 Oct 2018

Researchers test how ecolabels for sustainably harvested seafood affect consumer choices

How does labelling products and putting up signs in stores affect consumer choices, especially if you are trying to encourage consumers to buy sustainable seafood?

29 Oct 2018

Study investigates how brain lesion affects child’s language localization and abilities

Children with brain injuries are able to reorganize their language relevant areas into other, healthy brain areas and thus maintain their ability to speak.

29 Oct 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).

29 Oct 2018

Consequence-based cognitive training may be more effective, studies suggest

Interventions aimed at reducing unhealthy behaviors often focus on retraining people's mental associations, but a series of studies suggests that showing people the consequences of the behaviors may be more effective.

29 Oct 2018

Toxic effects of drugs in the lungs 'more widespread than thought'

A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat a range of common conditions is much more widespread than thought.

29 Oct 2018

Getting right level of leptin may help protect cardiovascular health

Like that famous bowl of porridge, when leptin levels are "just right" they help protect our cardiovascular health, scientists say.

29 Oct 2018

Melatonin may help children with sleep problems

Similar to adults, children too suffer from sleep problems such as insomnia that causes inadequate and non-restful sleep.

29 Oct 2018

Air pollution is the new tobacco says WHO Head

The head of the World Health Organization has said that air pollution is the “new tobacco” and breathing polluted air is killing 7 million people annually and harming billions of the population additionally.

29 Oct 2018

New approach may lead to protective vaccines for immunocompromised patients

A study led by Som Nanjappa at the University of Illinois College of Veterinary Medicine identifies a cellular target that may improve efficacy in vaccines designed to protect immunocompromised individuals from potentially deadly opportunistic infections.

26 Oct 2018

UC Riverside evolutionary biologist reveals why tall people are more prone to cancer

For most cancers, risk increases dramatically with age. But what about the effect of having more cells in the body? Might taller people be more prone to cancer because they have more cells?

26 Oct 2018

Medical News

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

Home blood pressure measurements can be used to diagnose hypertension in U.S. adults

Experimental vaccine shows promise to protect stroke survivors from blood clots

Dialysis giant Davita defends itself in court and at the polls

Study finds kill code mechanism embedded in every cell to extinguish cancer

Study reveals one in ten people may opt-out of proposed system for organ donation

Researchers develop new app that reminds users to relax and prevent stress

That’s a lot of scratch: The $48,329 allergy test

Researchers test how ecolabels for sustainably harvested seafood affect consumer choices

Study investigates how brain lesion affects child’s language localization and abilities

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Consequence-based cognitive training may be more effective, studies suggest

Toxic effects of drugs in the lungs 'more widespread than thought'

Getting right level of leptin may help protect cardiovascular health

Melatonin may help children with sleep problems

Air pollution is the new tobacco says WHO Head

New approach may lead to protective vaccines for immunocompromised patients

UC Riverside evolutionary biologist reveals why tall people are more prone to cancer

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News